Delcath Systems vs Pulmonx
Delcath Systems and Pulmonx are similar in size: $85.2m and $90.5m of revenue in their latest fiscal years. Delcath Systems grew faster (129.1% against 8.0%). Delcath Systems kept more of each dollar of sales as profit: a net margin of 3.2% against -59.7%. Delcath Systems carries less debt relative to equity (0.0% against 78.5%).
| Latest fiscal year | Delcath SystemsDCTH, 2025 | PulmonxLUNG, 2025 |
|---|---|---|
| Revenue | $85.2m | $90.5m |
| Revenue growth | 129.1% | 8.0% |
| Net income | $2.7m | −$54.0m |
| Operating margin | 0.8% | -59.3% |
| Net margin | 3.2% | -59.7% |
| Return on equity | 3.0% | -77.2% |
| Free cash flow | $21.0m | −$32.8m |
| Cash | $43.5m | $69.8m |
| Total debt | $0 | $42.5m |
| Debt to equity | 0.0% | 78.5% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $6.0m | — |
| Employees | 156 | 296 |
| Market value | $500m | $114m |
| Price vs our value range | — | — |
| Moat score | 25 (Weak) | 35 (Weak) |
| Insider trades, 12 months | 4 buys, 0 sales | 0 buys, 55 sales |